Latest news with #VFC
Yahoo
30-07-2025
- Business
- Yahoo
V.F. (VFC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
V.F. (VFC) reported $1.76 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 7.7%. EPS of -$0.24 for the same period compares to -$0.33 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.69 billion, representing a surprise of +3.96%. The company delivered an EPS surprise of +31.43%, with the consensus EPS estimate being -$0.35. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how V.F. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Geographic Revenue- Americas: $937.6 million versus the three-analyst average estimate of $951.6 million. The reported number represents a year-over-year change of -10.3%. Geographic Revenue- Europe: $551.3 million versus $495.87 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -0.3% change. Geographic Revenue- Asia-Pacific: $271.8 million versus the three-analyst average estimate of $278.36 million. The reported number represents a year-over-year change of -12.2%. Revenue- Outdoor: $812.47 million versus the six-analyst average estimate of $832.32 million. The reported number represents a year-over-year change of +2.8%. Revenue- Active: $699.69 million versus the six-analyst average estimate of $691.15 million. The reported number represents a year-over-year change of -25.7%. Revenue by Brand- The North Face: $557.4 million versus $523.34 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.3% change. Revenue by Brand- Vans: $498 million versus $472.72 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -14.4% change. Revenue by Brand- Timberland: $255.1 million versus the three-analyst average estimate of $230.92 million. The reported number represents a year-over-year change of +11.2%. Revenue by Channel- Direct-To-Consumer: $720.7 million versus $748.72 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -18% change. Segment profit (loss)- Active: $56.84 million versus $66.22 million estimated by three analysts on average. Segment profit (loss)- Outdoor: $-42.27 million versus $-78.77 million estimated by three analysts on average. View all Key Company Metrics for V.F. here>>> Shares of V.F. have returned +1.3% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report V.F. Corporation (VFC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
22-07-2025
- Business
- Business Insider
VF (VFC) Receives a Hold from Goldman Sachs
In a report released yesterday, Brooke Roach from Goldman Sachs maintained a Hold rating on VF, with a price target of $11.50. The company's shares closed yesterday at $12.45. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Roach is a 4-star analyst with an average return of 6.0% and a 51.63% success rate. Roach covers the Consumer Cyclical sector, focusing on stocks such as Kontoor Brands, Kohl's, and Nike. In addition to Goldman Sachs, VF also received a Hold from TR | OpenAI – 4o's Vince Stitcher in a report issued on July 12. However, on July 16, Williams Trading downgraded VF (NYSE: VFC) to a Sell. Based on VF's latest earnings release for the quarter ending March 29, the company reported a quarterly revenue of $2.14 billion and a GAAP net loss of $150.79 million. In comparison, last year the company earned a revenue of $2.37 billion and had a GAAP net loss of $418.31 million Based on the recent corporate insider activity of 31 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VFC in relation to earlier this year. Most recently, in May 2025, Richard Carucci, a Director at VFC bought 50,000.00 shares for a total of $602,500.00.
Medscape
11-07-2025
- Health
- Medscape
Unpacking the ACIP Overhaul: Chaos and Controversy
This transcript has been edited for clarity. This edition of Medicine Matters underscores the chaos and controversy at the June 2025 Advisory Committee on Immunization Practices (ACIP) meeting. What Is ACIP and Why Are ACIP Recommendations So Important? ACIP was established in 1964, and its charge was to make vaccine recommendations for the entire country. For years, ACIP's collaborative, transparent, and evidence-based process has been trusted by clinicians and helped protect Americans from vaccine-preventable diseases. ACIP recommendations are directly tied to insurance coverage. ACIP-recommended vaccines on the child and adult immunization schedules have to be covered by Affordable Care Act (ACA)-compliant insurance plans. ACIP also makes recommendations about which vaccines should be included in the Vaccines for Children (VFC) program. VFC ensures every child in America has access to vaccines — even if their parents can't afford them. This program provides vaccines to 50% of children in this country. I've been a liaison to ACIP for nearly two decades. In those 20 years, during both Republican and Democratic administrations, I've observed ACIP to be the crown jewel of our public health system, preventing hundreds of thousands of hospitalizations and deaths and untold suffering. ACIP has also been a beacon of trust for physicians and the public when it comes to vaccines. ACIP Overhaul Leads to Controversy at the June Meeting That crown jewel was blown apart in early June when the new HHS Secretary, Robert F. Kennedy, Jr, removed all 17 ACIP members, claiming — but not explaining — supposed conflicts of interest. Many of Kennedy's eight handpicked replacements have gone on record with preconceived bias against vaccines. One appointee withdrew his name due to financial conflict-of-interest concerns. For a few days, it seemed "touch-and-go" as to whether the meeting would even happen. Senator Bill Cassidy, the physician who chairs the Senate HELP Committee, was so concerned about the qualifications of this new panel that he wanted the meeting to be delayed. The draft agenda for June's ACIP meeting, first posted mid-June, was significant in itself for what it did not include. A highly anticipated discussion and vote on HPV vaccines was entirely omitted. The agenda also lacked a vote for COVID vaccines. On Tuesday, May 27, HHS Secretary Kennedy made an HHS directive and unilaterally removed COVID vaccines from the immunization schedule for healthy children and for pregnant women. He made this announcement on social media. No new evidence was cited to support this decision. Absent from this announcement was any representative from the CDC or ACIP. A new addition to the ACIP agenda — a thimerosal presentation by Lyn Redwood— was probably the most controversial. Her presentation slides that were originally posted on the ACIP website initially cited a study that didn't exist and did not accurately represent conclusions of other articles that do exist. A CDC review of the evidence debunked thimerosal myths and refuted Redwood's comments. This CDC review (initially put up on the ACIP website and then abruptly taken down) clarified that all childhood vaccines licensed and recommended in the US have been thimerosal-free since 2001, with the exception of some multidose formulations of flu vaccines. It also explained the evidence does not support an association between thimerosal-containing vaccines and autism spectrum disorder or other neurodevelopmental disorders. When it came time to vote, the new panel reaffirmed routine annual flu vaccination for everyone 6 months or older. But when additional votes involved thimerosal, all but one member ignored the true scientific evidence. Six of the seven members of the panel voted to remove thimerosal from flu shots for children, pregnant women, and adults. The only one who followed the evidence and voted against this decision was the sole pediatrician on the panel, Dr Cody Meissner. Dr Meissner previously served on the ACIP and explained, "The risk from influenza is so much greater than the nonexistent, as far as we know, risk from thimerosal." Concerning Comments From ACIP's New Chair The new chair of the ACIP, Martin Kulldorff, PhD, called for ' a review of long-approved vaccines.' He said ACIP will be taking a look at the cumulative effect of the recommended vaccine schedules, including interaction effects between different vaccines, the total number of vaccines, cumulative amounts of vaccine ingredients, and the relative timing of different vaccines. The current child and adult schedules are evidence-based and have been in place for long periods of time. This type of review could totally upend the child and adult immunization schedules as we know them. Kulldorff also explained that ACIP will be taking a new look at use of the MMR and varicella vaccine for young children. Further, he announced that a new vaccine work group may look at the need for the universally recommended hepatitis B vaccine dose on the day of birth — a cornerstone of hepatitis B prevention for the entire population. The American Academy of Pediatrics (AAP) has already pushed back on social media, explaining that passing the virus from parent to baby at birth can be deadly. Medical Organizations Speak Out and Push Back Meanwhile, organized medicine has gone on the offensive. The AAP showed its disapproval by boycotting the meeting. The American Medical Association (AMA) released a statement that this removal of ACIP's 17 qualified members 'undermines that trust and upends a transparent process that has saved countless lives.' The AMA, along with 78 other medical organizations, also issued an open letter to the public, backing vaccination as the best way to protect against respiratory viruses, including flu, COVID, and RSV, and their potentially serious complications. These organizations called on insurers, hospitals, and public health agencies to ensure these life-saving vaccines remain available to patients without cost-sharing. Many physicians and other clinicians are looking for alternatives for vaccination guidance now that it seems the CDC can no longer be their "North Star." Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, is already launching the Vaccine Integrity Project. An Unclear Future for Vaccine Policy and Public Health This is the tragic bottom line: ACIP was put on life support when all 17 of the remarkable physicians, scientists, and vaccine experts were fired for clearly political reasons. This first ACIP meeting since that purge confirmed our worst fears. It gave platform and voice to an unscientific, debunked presentation on the vaccine preservative thimerosal, given by someone who was clearly unqualified and uncredentialed to even address this issue. ACIP is supposed to address vaccine policy that can bring health and happiness — not death and illness — to our country. America's physicians try to work collaboratively with everyone at these public health agencies to advance the nation's health. But physicians must also stand up for our patients. We must push back on misinformation, medical foolishness, and quackery. Unfortunately, that is the only way to describe that thimerosal presentation and — more importantly — the 6-1 vote that adopted the debunked thimerosal presentation as ACIP policy. Misinformation is designed to stoke mistrust in vaccines. Mistrust reduces vaccine uptake, and reduced vaccine uptake kills and sickens our patients. We wouldn't be in the midst of a measles outbreak but for vaccine hesitancy. If this is what we can expect out of the new ACIP, physicians need to get ready for more suffering and death — because that is surely what is coming.
Business Wire
12-06-2025
- Business
- Business Wire
Marqeta to Power New Klarna Debit Card in the U.S.
OAKLAND, Calif.--(BUSINESS WIRE)--Marqeta, Inc. (NASDAQ: MQ), the global modern card issuing platform that enables embedded finance solutions for the world's innovators, today announced it is working with Klarna, the global digital bank and flexible payments provider, to enable the Klarna Card: a new debit card powered by Visa Flexible Credential (VFC) that allows access to built-in flexible payment options. In July 2024, Marqeta became the first issuer processor in the U.S. certified for Visa Flexible Credential. With VFC, Marqeta will enable Klarna customers to pay immediately or pay later when needed, all on the same card. This milestone builds on years of collaboration between Marqeta and Klarna, including powering Klarna's virtual cards in the U.S. since 2018. The card is currently in a trial phase in the U.S., with a broader rollout in the U.S. expected later this year. 'The future of payments is flexible, and we're proud to enable this new offering together with Visa,' said Rahul Shah, Chief Product and Engineering Officer, Marqeta. 'Our ongoing partnership with Klarna is a true testament to what's possible with Marqeta's platform and how we enable our customers to grow and innovate at global scale.' With its modern, flexible card issuing platform, Marqeta makes it possible for global leaders like Klarna to expand to new markets and offer innovative payment options tailored to evolving customer needs. Marqeta currently supports Klarna in six countries, helping to drive global growth and deliver seamless, consumer-first experiences. "Through our continued partnership with Marqeta and Visa, we're evolving the Klarna Card into a truly dynamic and versatile payment experience,' said David Sandström, Chief Marketing Officer, Klarna. 'We're excited to continue innovating alongside Marqeta as we scale the Klarna Card to provide smart, seamless payments that empower smarter, more informed shoppers everywhere." About Marqeta Marqeta makes it possible for companies to build and embed financial services into their branded experience—and unlock new ways to grow their business and delight users. The Marqeta platform puts businesses in control of building financial solutions, enabling them to turn real-time data into personalized, optimized solutions for everything from consumer loyalty to capital efficiency. With compliance and security built-in, Marqeta's platform has been proven at scale, processing nearly $300 billion in annual payments volume in 2024. Marqeta is certified to operate in more than 40 countries worldwide. Visit to learn more. About Klarna Klarna is a global digital bank and flexible payments provider. With over 100 million global active Klarna users and 2.9 million transactions per day, Klarna's AI-powered payments and commerce network is empowering people to pay smarter with a mission to be available everywhere for everything. Consumers can pay with Klarna online, in-store and through Apple Pay in the U.S., UK and Canada. More than 724,000 retailers trust Klarna's innovative solutions to drive growth and loyalty, including Uber, H&M, Saks, Sephora, Macy's, Ikea, Expedia Group, Nike and Airbnb. For more information, visit About Visa Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this press release include, but are not limited to, quotations and statements relating to changing consumer preferences; increasing consumer adoption of certain digital payment methods, products, and solutions; which payment, banking, and financial services products and solutions may succeed; technological and market trends; Marqeta's business; Marqeta's products and services; and statements made by Marqeta's senior leadership. Actual results may differ materially from the expectations contained in these statements due to risks and uncertainties, including, but not limited to, the following: any factors creating issues with changes in domestic and international business, market, financial, political and legal conditions; and those risks and uncertainties included in the 'Risk Factors' disclosed in Marqeta's Annual Report on Form 10-K, as may be updated from time to time in Marqeta's periodic filings with the SEC, available at and Marqeta's website at The forward-looking statements in this press release are based on information available to Marqeta as of the date hereof. Marqeta disclaims any obligation to update any forward-looking statements, except as required by law.
Associated Press
12-06-2025
- Business
- Associated Press
Marqeta to Power New Klarna Debit Card in the U.S.
OAKLAND, Calif.--(BUSINESS WIRE)--Jun 12, 2025-- Marqeta, Inc. (NASDAQ: MQ), the global modern card issuing platform that enables embedded finance solutions for the world's innovators, today announced it is working with Klarna, the global digital bank and flexible payments provider, to enable the Klarna Card: a new debit card powered by Visa Flexible Credential (VFC) that allows access to built-in flexible payment options. In July 2024, Marqeta became the first issuer processor in the U.S. certified for Visa Flexible Credential. With VFC, Marqeta will enable Klarna customers to pay immediately or pay later when needed, all on the same card. This milestone builds on years of collaboration between Marqeta and Klarna, including powering Klarna's virtual cards in the U.S. since 2018. The card is currently in a trial phase in the U.S., with a broader rollout in the U.S. expected later this year. 'The future of payments is flexible, and we're proud to enable this new offering together with Visa,' said Rahul Shah, Chief Product and Engineering Officer, Marqeta. 'Our ongoing partnership with Klarna is a true testament to what's possible with Marqeta's platform and how we enable our customers to grow and innovate at global scale.' With its modern, flexible card issuing platform, Marqeta makes it possible for global leaders like Klarna to expand to new markets and offer innovative payment options tailored to evolving customer needs. Marqeta currently supports Klarna in six countries, helping to drive global growth and deliver seamless, consumer-first experiences. 'Through our continued partnership with Marqeta and Visa, we're evolving the Klarna Card into a truly dynamic and versatile payment experience,' said David Sandström, Chief Marketing Officer, Klarna. 'We're excited to continue innovating alongside Marqeta as we scale the Klarna Card to provide smart, seamless payments that empower smarter, more informed shoppers everywhere.' About Marqeta Marqeta makes it possible for companies to build and embed financial services into their branded experience—and unlock new ways to grow their business and delight users. The Marqeta platform puts businesses in control of building financial solutions, enabling them to turn real-time data into personalized, optimized solutions for everything from consumer loyalty to capital efficiency. With compliance and security built-in, Marqeta's platform has been proven at scale, processing nearly $300 billion in annual payments volume in 2024. Marqeta is certified to operate in more than 40 countries worldwide. Visit to learn more. About Klarna Klarna is a global digital bank and flexible payments provider. With over 100 million global active Klarna users and 2.9 million transactions per day, Klarna's AI-powered payments and commerce network is empowering people to pay smarter with a mission to be available everywhere for everything. Consumers can pay with Klarna online, in-store and through Apple Pay in the U.S., UK and Canada. More than 724,000 retailers trust Klarna's innovative solutions to drive growth and loyalty, including Uber, H&M, Saks, Sephora, Macy's, Ikea, Expedia Group, Nike and Airbnb. For more information, visit About Visa Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this press release include, but are not limited to, quotations and statements relating to changing consumer preferences; increasing consumer adoption of certain digital payment methods, products, and solutions; which payment, banking, and financial services products and solutions may succeed; technological and market trends; Marqeta's business; Marqeta's products and services; and statements made by Marqeta's senior leadership. Actual results may differ materially from the expectations contained in these statements due to risks and uncertainties, including, but not limited to, the following: any factors creating issues with changes in domestic and international business, market, financial, political and legal conditions; and those risks and uncertainties included in the 'Risk Factors' disclosed in Marqeta's Annual Report on Form 10-K, as may be updated from time to time in Marqeta's periodic filings with the SEC, available at and Marqeta's website at The forward-looking statements in this press release are based on information available to Marqeta as of the date hereof. Marqeta disclaims any obligation to update any forward-looking statements, except as required by law . View source version on CONTACT: Kelly Kraft [email protected] 623-363-5007 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA OHIO INDUSTRY KEYWORD: SOFTWARE PAYMENTS FINANCE ARTIFICIAL INTELLIGENCE BANKING DATA MANAGEMENT PROFESSIONAL SERVICES TECHNOLOGY SOURCE: Marqeta Copyright Business Wire 2025. PUB: 06/12/2025 07:00 AM/DISC: 06/12/2025 07:01 AM
